Anticoagulants Market Surpass $39 Billion By 2026 | CAGR 7.9%

Author: Acumen Research and Consulting

The international anticoagulants market is predicted to hit USD 39 billion by 2026, this market is estimated to grow with 7.9% CAGR during the coming years. Increasing geriatric population at global level is one of the prime factors foreseen to fuel the demand for anticoagulant market.

Increasing cases of heart attacks and strokes

From the past few years, the factors such as changing lifestyles, increasing consumption of junk food, and sedentary lifestyle are resulting into rise in blood pressure and diabetic patients. The patients with these diseases are highly inclined towards getting heart attacks, strokes, or coagulations in blood. The number of deaths due to heart attacks are increasing significantly.

  • According to CDC (Centers of Disease Control and Prevention) in United States about 1 in every 4 deaths is caused due to heart diseases in every year and that’s 610,000 people every year.
  • Also, about 735,000 Americans have a heart attack in one year and out of these 525,000 are a case of first heart attack and remaining 210,000 are the one who already had a heart attack.

Download Report Sample Pages For Better Understanding@ 

Such increase in heart diseases is one of the crucial factors due to which the consumption and demand for anticoagulants is increasing rapidly.

Constant Research and Development

The healthcare organisations and control authorities such as WHO (World Health Organization), American Heart Association (AHA), American College of Cardiology (ACC) and Heart Rhythm Society (HRS), and others are increasing focusing on research and development in the anticoagulants. The research is primarily aimed at lowering the other side effects of the anticoagulants as there is lack of awareness about the side effects of oral anticoagulants. The organizations are coming up with new guidelines for the industry to maintain a standardised content of the anticoagulants and lessen the side effects and life hazards.

  • For example, in January 2019 the healthcare organization present in America together announced the updated the guidelines for atrial fibrillation (AFib) treatment.
  • Through this updates organizations are now recommending a new oral anticoagulants (NOACs) which is considered as a preferred alternative to warfarin for reducing the risk of stroke.

Such initiative taken by these healthcare organizations is making a more improve anticoagulants available in the market which is another factor accelerating demand for the anticoagulants.

The global anticoagulants market is segmented into route of administration - Oral, and Injectable. On the basis of drug class, the anticoagulants market is segmented into Factor XA Inhibitors (NOAC/DOAC), Heparins, Direct Thrombin Inhibitors, Vitamin K Antagonists. On the basis of Indication, the global anticoagulants market is segmented into Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Atrial Fibrillation and Heart Attack. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. On the basis of region, the global Anticoagulants market is bifurcated into Europe, Latin America, North America, Middle East & Africa, and Asia Pacific.


The global increase in population, increasing disposable incomes, and rise in geriatric population are some of the other factors which are foreseen to fuel the demand for anticoagulants and hence drive the market growth.

North America was the dominant region in terms of demand and consumption of anticoagulants in 2018 and similar trend is expected to continue over forecast period.The rise in coagulation disease across different age groups and increasing surgery operations for knee and hips majorly are some of the prime factors boosting the demand for anticoagulants in this region. In addition to this, dense presence of anticoagulants manufacturers is another factor which is making North America a leader in this market. The Asia Pacific region is expected to be the fastest growing region in terms of demand of anticoagulants owing to increasing disposable income and rise in health issues in this region is fuelling the market growth. The increasing kidney diseases, heart diseases, strokes, and others is increasing need for using anticoagulants as a thinner agent for human blood for maintaining a required flow and such factor are making the anticoagulant an important part in healthcare area.

The players contributing in the global anticoagulants market are Pfizer, Inc., Johnson & Johnson Services, Inc.,Bayer Healthcare, Pfizer, Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company,Daiichi Sankyo Company Limited, and Sanofi.


The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report - 

Would like to place an order or any question, please feel free to contact at